Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?

Journal of Hepatology

Volumn 58, Issue 2, 2013, Pages 205-209

  Thimme, Robert ^a   Dandri, Maura ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Hepatitis B virus; Interferon; NK cells

Indexed keywords

ALPHA INTERFERON; HEPATITIS B VACCINE; NUCLEOSIDE ANALOG; PEGINTERFERON ALPHA;

CHRONIC DISEASE; COMBINATION CHEMOTHERAPY; HEPATITIS B; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MINICHROMOSOME; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS GENOME;

EID: 84872369702     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.11.007     Document Type: Editorial

References (46)

1. M. Levrero, T. Pollicino, J. Petersen, L. Belloni, G. Raimondo, and M. Dandri Control of cccDNA function in hepatitis B virus infection J Hepatol 51 2009 581 592
2. K. Visvanathan, N.A. Skinner, A.J. Thompson, S.M. Riordan, V. Sozzi, and R. Edwards Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein Hepatology 45 2007 102 110
3. ML. Op den Brouw, RS. Binda, MH. van Roosmalen, U. Protzer, HL. Janssen, and RG. van der Molen Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus Immunology 126 2009 280 289
4. T. Lang, C. Lo, N. Skinner, S. Locarnini, K. Visvanathan, and A. Mansell The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway J Hepatol 55 2011 762 769
5. M. Lutgehetmann, T. Bornscheuer, T. Volz, L. Allweiss, J.H. Bockmann, and J.M. Pollok Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice Gastroenterology 2011
6. A. Das, M. Hoare, N. Davies, A.R. Lopes, C. Dunn, and P.T. Kennedy Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection J Exp Med 205 2008 2111 2124
7. C. Boni, P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, and T. Giuberti Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection J Virol 81 2007 4215 4225
8. EASL EASL clinical practice guidelines: management of chronic hepatitis B J Hepatol 50 2009 227 242
9. T. Nguyen, and S. Locarnini Hepatitis: monitoring drug therapy for hepatitis B- A global challenge? Nat Rev Gastroenterol Hepatol 6 2009 565 567
10. M.R. Brunetto, F. Moriconi, F. Bonino, G.K. Lau, P. Farci, and C. Yurdaydin Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B Hepatology 49 2009 1141 1150
11. S.F. Wieland, L.G. Guidotti, and F.V. Chisari Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice J Virol 74 2000 4165 4173
12. S.F. Wieland, A. Eustaquio, C. Whitten-Bauer, B. Boyd, and F.V. Chisari Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids Proc Natl Acad Sci USA 102 2005 9913 9917
13. S.L. Uprichard, S.F. Wieland, A. Althage, and F.V. Chisari Transcriptional and posttranscriptional control of hepatitis B virus gene expression Proc Natl Acad Sci USA 100 2003 1310 1315
14. C. Xu, H. Guo, X.B. Pan, R. Mao, W. Yu, and X. Xu Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus J Virol 84 2010 9332 9340
15. L. Belloni, L. Allweiss, F. Guerrieri, N. Pediconi, T. Volz, and T. Pollicino IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome J Clin Invest 122 2012 529 537
16. M.K. Maini, and A. Schurich The molecular basis of the failed immune response in chronic HBV: therapeutic implications J Hepatol 52 2010 616 619
17. S. Wieland, R. Thimme, R.H. Purcell, and F.V. Chisari Genomic analysis of the host response to hepatitis B virus infection Proc Natl Acad Sci USA 101 2004 6669 6674
18. C. Dunn, D. Peppa, P. Khanna, G. Nebbia, M. Jones, and N. Brendish Temporal analysis of early immune responses in patients with acute hepatitis B virus infection Gastroenterology 137 2009 1289 1300
19. R. Thimme, S. Wieland, C. Steiger, J. Ghrayeb, K.A. Reimann, and R.H. Purcell CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection J Virol 77 2003 68 76
20. M. Dandri, and S. Locarnini New insight in the pathobiology of hepatitis B virus infection Gut 61 Suppl 1 2012 i6 17
21. E. Billerbeck, T. Bottler, and R. Thimme Regulatory T cells in viral hepatitis World J Gastroenterol 13 2007 4858 4864
22. L. Micco, D. Peppa, E. Loggi, A. Schurich, L. Jefferson, and C. Cursaro Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B J Hepatol 58 2013 225 233
23. K.A. Stegmann, N.K. Bjorkstrom, H. Veber, S. Ciesek, P. Riese, and J. Wiegand Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection Gastroenterology 138 2010 1885 1897
24. C. Dunn, M. Brunetto, G. Reynolds, T. Christophides, P.T. Kennedy, and P. Lampertico Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage J Exp Med 204 2007 667 680
25. B. Oliviero, S. Varchetta, E. Paudice, G. Michelone, M. Zaramella, and D. Mavilio Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 137 2009 1151 1160 1160 e1151-1157
26. E.T. Tjwa, G.W. van Oord, J.P. Hegmans, H.L. Janssen, and A.M. Woltman Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B J Hepatol 54 2011 209 218
27. D. Peppa, L. Micco, A. Javaid, P.T. Kennedy, A. Schurich, and C. Dunn Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection PLoS Pathog 6 2010 e1001227
28. B. Kramer, C. Korner, M. Kebschull, A. Glassner, M. Eisenhardt, and H.D. Nischalke Natural killer p46 (High) expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis Hepatology 56 2012 1201 1213
29. L. Golden-Mason, A.L. Cox, J.A. Randall, L. Cheng, and H.R. Rosen Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro Hepatology 52 2010 1581 1589
30. M. Heeg, and R. Thimme Natural killer cells and hepatitis C: natural killer p46 expression linked to antiviral and antifibrotic activity Hepatology 56 2012 1197 1200
31. A. Penna, D. Laccabue, I. Libri, T. Giuberti, S. Schivazappa, and A. Alfieri Peginterferon-alpha does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis J Hepatol 56 2012 1239 1246
32. C. Boni, D. Laccabue, P. Lampertico, T. Giuberti, M. Vigano, and S. Schivazappa Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues Gastroenterology 143 963-973 2012 e969
33. P. Marcellin, G.K. Lau, F. Bonino, P. Farci, S. Hadziyannis, and R. Jin Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B N Engl J Med 351 2004 1206 1217
34. H.L. Janssen, M. van Zonneveld, H. Senturk, S. Zeuzem, U.S. Akarca, and Y. Cakaloglu Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial Lancet 365 2005 123 129
35. K. Wursthorn, M. Lutgehetmann, M. Dandri, T. Volz, P. Buggisch, and B. Zollner Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B Hepatology 44 2006 675 684
36. M. Lutgehetmann, T. Volzt, A. Quaas, M. Zankel, C. Fischer, and M. Dandri Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication Antivir Ther 13 2008 57 66
37. L. Allweiss, M. Lütgehetmann, T. Volz, T. Bornscheuer, A.W. Lohse, and J. Petersen Pegylated-interferon-alpha alone or in combination with entecavir restores ISG responsiveness and reduces intrahepatic viral loads and antigenemia in hepatitis B virus infected humanized mice J Hepatol 56 2012 S18 S19
38. J.M. Kittner, M.F. Sprinzl, A. Grambihler, A. Weinmann, J.M. Schattenberg, and P.R. Galle Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B J Clin Virol 54 2012 93 95
39. M. Lutgehetmann, T. Volz, A. Kopke, T. Broja, E. Tigges, and A.W. Lohse In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice Hepatology 52 2010 16 24
40. J. Petersen, M. Dandri, W. Mier, M. Lutgehetmann, T. Volz, and F. von Weizsacker Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein Nat Biotechnol 26 2008 335 341
41. A. Bertoletti, and C. Ferrari Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection Gut 2011
42. A. Schurich, P. Khanna, A.R. Lopes, K.J. Han, D. Peppa, and L. Micco Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-prone CD8 T cells in persistent hepatitis B virus infection Hepatology 53 2011 1494 1503
43. P. Fisicaro, C. Valdatta, M. Massari, E. Loggi, L. Ravanetti, and S. Urbani Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HB, V but not HCV Gastroenterology 2012
44. R.A. Morgan, M.E. Dudley, J.R. Wunderlich, M.S. Hughes, J.C. Yang, and R.M. Sherry Cancer regression in patients after transfer of genetically engineered lymphocytes Science 314 2006 126 129
45. U. Protzer, and H. Abken Can engineered "designer" T cells outsmart chronic hepatitis B? Hepat Res Treat 2010 2010 901216
46. F. Bohne, M. Chmielewski, G. Ebert, K. Wiegmann, T. Kurschner, and A. Schulze T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes Gastroenterology 134 2008 239 247